Alan Berger, MD

Assistant Professor of Medicine
Adjunct Assistant Professor of Epidemiology,
School of Public Health
Quality and Outcomes Director, Interventional Cardiology

Merging knowledge and experience in cardiology and epidemiology, Dr. Berger cares for individual patients, and for the heart health of the general public as well. In March 2010, he became the quality and outcomes director for interventional cardiology.

Dr. Berger’s clinical and interventional practices focus on the management of patients with coronary-artery disease and peripheral-arterial disease (blockages in the legs, and sometimes the arms). He treats adult patients of all ages, with a special interest in geriatric cardiology. He is the principal investigator for “Treatment of Acute Myocardial Infarction in the Elderly,” a study funded by the National Heart, Lung, and Blood Institute (NHLBI) with a K08 grant, and was a co-investigator for the Minnesota Heart Survey.Dr. Berger’s education includes an M.D. from the Jefferson Medical College (Philadelphia), medical residency at the Boston University Medical Center (now the Boston Medical Center), general- and interventional-cardiology fellowships at Georgetown University, and a combined interventional/epidemiology fellowship at Yale University. Dr. Berger is a dedicated and enthusiastic teacher of public-health graduate students and physicians-in-training, and has been the recipient of a University of Minnesota Cardiology Faculty Teaching Award. He presents educational seminars to established cardiologists on national and even international levels.

Professional Organizations

American College of Cardiology, member
American Heart Association, member
Americian Medical Association, member
Society for Cardiovascular Angiography and Interventions, member

Journal Review

Dr. Berger has served as a reviewer for several cardiology journals, The American Journal of Epidemiology, and the American Journal of Kidney Disease.

Selected Publications

Luepker RV, Berger AK. Is acute myocardial infarction disappearing? Circulation 2010;121:1280-1282

Berger AK, Herzog CA. Percutaneous coronary intervention vs. coronary-artery bypass grafting in CKD. Am J Kidney Dis 2010;55:15-20

Berger AK, Herzog CA.Connecting the Cs: Coronaries, creatinine, compliance, CRUSADE. Am J Kidney Dis 2009;53:366-369

Nguyen JT, Berger AK, Duval S, Luepker RV.Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J 2008;155:862-868

Berger AK, Duval S, Jacobs DR Jr, Barber C, Vazquez G, Lee S, Luepker RV. Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality. Am J Cardiol 2008;101:428-434

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J 2007;153:1064-1073

Svensson AM, Dellborg M, Abrahamsson P, Karlsson T, Herlitz J, Duval SJ, Berger AK, Luepker RV. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Int J Cardiol 2007;119:319-325